Clinical Trials Logo

Tinnitus clinical trials

View clinical trials related to Tinnitus.

Filter by:

NCT ID: NCT05292534 Completed - Tinnitus Clinical Trials

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

NCT ID: NCT05291078 Completed - Tinnitus Clinical Trials

Study of Application of Transcutaneous Trigeminal Nerve Stimulation and Sound Fusion Stimulation on Tinnitus

Start date: October 22, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy of applying transcutaneous trigeminal nerve stimulation (NUEYNE-T30, NUEYNE-T100) and sound fusion stimulation on tinnitus.

NCT ID: NCT05271825 Completed - Clinical trials for Tinnitus, Subjective

Broadband Amplification as Tinnitus Treatment

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

- The effect of broadband amplification was tested in a double-blinded crossover study - Its effect was compared to an active placebo treatment - An improvement in tinnitus distress was found after use of broadband amplification - No effect was found on the tinnitus loudness

NCT ID: NCT05268770 Not yet recruiting - Inflammation Clinical Trials

Inflammation in Tinnitus

INFLATIN
Start date: March 2022
Phase:
Study type: Observational [Patient Registry]

Rationale: Tinnitus is the perception of sound without an external source. In the past decade, inflammation has been implicated in the pathophysiology of tinnitus. In animal models of tinnitus, the expression of proinflammatory cytokines Tumor Necrosis Factor-α (TNF-α) and interleukine-1β (IL-1β) was increased throughout the whole auditory tract. Only two studies evaluated cytokine concentrations in tinnitus patients. In these studies an increase of IL-6 and decrease of IL-10 have been objectified. However, studies did not include tinnitus patients based on the degree of hearing loss, despite that inflammation has also been implicated in hearing loss. On the other hand, studies about inflammation in hearing loss did not (always) exclude tinnitus. Thus, it remains unclear whether the upregulated cytokine concentrations the studies are specific for tinnitus, and whether potential effects remained unsignificant because the presence of hearing loss is a confounder. Therefore, the aim of this study is to evaluate the presence of inflammation in tinnitus patients with normal hearing. Objective: The main objective is to evaluate the presence of inflammation in blood samples of human subjects with tinnitus and normal hearing, compared to healthy controls. The secondary objective is to evaluate the relation between tinnitus severity and inflammatory marker concentrations. Study design: This is a cross-sectional study. Study population: Patients who have been referred to the tinnitus consultation at the outpatient clinic will be asked to participate in this study. For the control group, healthy volunteers will be recruited. Main study parameters/endpoints: The main study parameter is the disparity in blood cytokine levels between participants with and without tinnitus. Secondary study parameters are the relation between tinnitus severity and blood cytokine concentration, and the difference in complete blood count measures in participants with and without tinnitus.

NCT ID: NCT05265949 Completed - Obesity Clinical Trials

The Effects of Weight Loss on Tinnitus Symptoms

Start date: April 23, 2019
Phase: N/A
Study type: Interventional

Subjective tinnitus is the perception of irregular sound at different frequencies. Although the underlying cause of tinnitus is unclear, increased body weight is known to increase tinnitus symptoms. This study aimed to determine the effects of dietary and physical activity interventions on tinnitus symptoms. Sixty-three obese subjects with tinnitus aged 20 to 65 years were divided into diet + physical 8 activity (P.A.), diet, P.A., and control groups. Dietary and anthropometric records, Tinnitus Handicap 9Inventory (THI), Beck Depression Inventory (BDI), Short-Form Health Survey (SF-36), and Visual Analogue Scale (VAS) of all individuals were compared at the baseline and at the end of the study.

NCT ID: NCT05245318 Recruiting - Tinnitus Clinical Trials

The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment

CATT
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The twofold aim of this single-blind two-arm 1:1 randomised control trial is to examine if the treatment effect and cost-effectiveness of a smartphone application, designed to increase therapy compliance and provide tinnitus counselling, as part of a blended physiotherapy program, is, as hypothesised, as good as or better in comparison to standard clinical care.

NCT ID: NCT05227365 Completed - Tinnitus Clinical Trials

Treatment Evaluation of Neuromodulation for Tinnitus - Stage A3

TENT-A3
Start date: March 21, 2022
Phase: N/A
Study type: Interventional

TENT-A3 is a single arm repeated measures prospective investigation evaluating the safety and efficacy of the Lenire device for tinnitus treatment. The Lenire device provides non-invasive bimodal (sound and tongue) stimulation to alleviate the symptoms of chronic, subjective tinnitus. Participants presenting to one of the several study sites with a diagnosis of chronic subjective tinnitus who meet the inclusion criteria are enrolled in the investigation while the study site is active. The objective of TENT-A3 is to determine whether the addition of tongue stimulation to sound-only stimulation provides additional clinically significant improvements in tinnitus symptoms beyond that of the sound-only stimulation component of the bimodal treatment.

NCT ID: NCT05212298 Recruiting - Tinnitus Clinical Trials

Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus

Start date: September 16, 2021
Phase: N/A
Study type: Interventional

This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method. 120 adults were divided into 3 groups. 1. Control group: receive placebo treatment, once a day, four pills each time. 2. Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg. 3. Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg. All subjects received health questionnaire, sleep questionnaire and tinnitus questionnaire before the start of the test At the end of the treatment(3 months), the health questionnaire, sleep questionnaire, and tinnitus questionnaire were accepted.

NCT ID: NCT05198973 Recruiting - Clinical trials for Tinnitus, Subjective

Bumblebee Breath Effect on Tinnitus in Older Patients

Start date: November 8, 2021
Phase: N/A
Study type: Interventional

Tinnitus is a condition in which the person hears sound, which isn't coming from the external environment, often, described as ringing in the ears. Patients describe the condition as an annoyance and disturbance and in turn this correlates with increased levels of anxiety and depression. Currently, there is no single effective treatment for tinnitus so research continues to look for new ways to treat and manage the condition. Bumblebee Breath starts by finding a relaxed, supported posture, either laying supine or in seated and then bringing the minds attention to the space between the eyebrows (or third eye in yoga terms). With the eyes close the thumbs are placed over the tragus of the ears, the first finger gently rests on eye lids, middle finger touches the sides of the nose and then the index and pinkie rest just above and below the closed lips. Next, a sound is created by inhaling deeply through the nose and exhaling with a low-pitched humming sound. The result sounds very much like a bee buzzing to the person performing the breath and a sensation of vibration is experienced inside the head and over the face. this study is designed to assess Bumblebee Breath on tinnitus.

NCT ID: NCT05189587 Not yet recruiting - Depression Clinical Trials

Home-based Transcranial Electrical Stimulation (TES) in Patients With Chronic Tinnitus

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The investigators applied home-based transcranial electrical stimulation (TES) for neuromodulative treatment in patients with intractable chronic tinnitus.